The study, sponsored by Chang Gung Memorial Hospital, investigates the interplay between vascular injury, amyloid plaques, and tau proteins in cognitive dysfunction following stroke. With approximately one-third of stroke patients developing post-stroke dementia, this research addresses a significant unmet medical need in the aging population. The findings could inform the development of diagnostic tools or therapeutic strategies targeting cognitive impairment in stroke patients, potentially positioning the sponsor as a leader in this niche market. The competitive landscape includes other neuroimaging studies and dementia-related therapeutics, necessitating a thorough diligence assessment to identify potential collaborators or competitors in the field.